Predicting biochemical recurrence after radical prostatectomy: the role of prognostic grade group and index tumor nodule

Nuno Vau, Vanessa Henriques, Liang Cheng, Ana Blanca, Jorge Fonseca, Rodolfo Montironi, Alessia Cimadamore, Antonio Lopez-Beltran

Research output: Contribution to journalArticle

Abstract

The aim of the current study was to test whether the grade group assessed in the index tumor nodule predicts biochemical recurrence after surgery. The study cohort series included 144 consecutive patients treated by laparoscopic radical prostatectomy. The following parameters were evaluated in each case: type of radical prostatectomy (with/without lymphadenectomy), pT and pN status, histologic type of prostate carcinoma (acinar versus mixed histology), surgical margin resection status, perineural invasion, lymphovascular invasion, biochemical recurrence status, presence of tertiary Gleason 5 pattern, and grade group that was assessed both in overall prostate cancer and in index (dominant) tumor nodule. Twenty patients (13.9%) experienced postoperative biochemical recurrence at a mean follow-up time of 12.2 months. The univariate survival analysis selected type of radical prostatectomy, histological subtype, lymphovascular invasion, American Joint Committee on Cancer pT and pN classification, tertiary Gleason 5 pattern, preoperative serum prostate specific antigen level, and the grade group assessed in both the overall prostate and index tumor nodule as significant for biochemical recurrence-free survival. Type of radical prostatectomy (P = .020), histological subtype (P = .002), lymphovascular invasion (P = .023), tertiary Gleason pattern 5 (P = .016), and grade group classification in index tumor nodule (P ≤ .0001) were selected as independent predictors of biochemical recurrence-free survival. In conclusion, our results validate grade group in the index tumor nodule as an independent predictor of biochemical recurrence-free survival, thus emphasizing the value of reporting grade group in index tumor nodule. The main limitation of our study is the relatively low number of cases in the current series, suggesting the need of large confirmatory studies.

Original languageEnglish (US)
Pages (from-to)6-15
Number of pages10
JournalHuman pathology
Volume93
DOIs
StatePublished - Nov 2019

Fingerprint

Prostatectomy
Recurrence
Neoplasms
Survival
Prostate
Acinar Cell Carcinoma
Prostate-Specific Antigen
Survival Analysis
Lymph Node Excision
Prostatic Neoplasms
Histology
Cohort Studies
Serum

Keywords

  • Biochemical recurrence
  • Grade groups
  • Index nodule
  • Index tumor
  • Prostate cancer
  • Radical prostatectomy

ASJC Scopus subject areas

  • Pathology and Forensic Medicine

Cite this

Predicting biochemical recurrence after radical prostatectomy : the role of prognostic grade group and index tumor nodule. / Vau, Nuno; Henriques, Vanessa; Cheng, Liang; Blanca, Ana; Fonseca, Jorge; Montironi, Rodolfo; Cimadamore, Alessia; Lopez-Beltran, Antonio.

In: Human pathology, Vol. 93, 11.2019, p. 6-15.

Research output: Contribution to journalArticle

Vau, Nuno ; Henriques, Vanessa ; Cheng, Liang ; Blanca, Ana ; Fonseca, Jorge ; Montironi, Rodolfo ; Cimadamore, Alessia ; Lopez-Beltran, Antonio. / Predicting biochemical recurrence after radical prostatectomy : the role of prognostic grade group and index tumor nodule. In: Human pathology. 2019 ; Vol. 93. pp. 6-15.
@article{6a7c692e472c4fb48f8d92b9b5dbcfff,
title = "Predicting biochemical recurrence after radical prostatectomy: the role of prognostic grade group and index tumor nodule",
abstract = "The aim of the current study was to test whether the grade group assessed in the index tumor nodule predicts biochemical recurrence after surgery. The study cohort series included 144 consecutive patients treated by laparoscopic radical prostatectomy. The following parameters were evaluated in each case: type of radical prostatectomy (with/without lymphadenectomy), pT and pN status, histologic type of prostate carcinoma (acinar versus mixed histology), surgical margin resection status, perineural invasion, lymphovascular invasion, biochemical recurrence status, presence of tertiary Gleason 5 pattern, and grade group that was assessed both in overall prostate cancer and in index (dominant) tumor nodule. Twenty patients (13.9{\%}) experienced postoperative biochemical recurrence at a mean follow-up time of 12.2 months. The univariate survival analysis selected type of radical prostatectomy, histological subtype, lymphovascular invasion, American Joint Committee on Cancer pT and pN classification, tertiary Gleason 5 pattern, preoperative serum prostate specific antigen level, and the grade group assessed in both the overall prostate and index tumor nodule as significant for biochemical recurrence-free survival. Type of radical prostatectomy (P = .020), histological subtype (P = .002), lymphovascular invasion (P = .023), tertiary Gleason pattern 5 (P = .016), and grade group classification in index tumor nodule (P ≤ .0001) were selected as independent predictors of biochemical recurrence-free survival. In conclusion, our results validate grade group in the index tumor nodule as an independent predictor of biochemical recurrence-free survival, thus emphasizing the value of reporting grade group in index tumor nodule. The main limitation of our study is the relatively low number of cases in the current series, suggesting the need of large confirmatory studies.",
keywords = "Biochemical recurrence, Grade groups, Index nodule, Index tumor, Prostate cancer, Radical prostatectomy",
author = "Nuno Vau and Vanessa Henriques and Liang Cheng and Ana Blanca and Jorge Fonseca and Rodolfo Montironi and Alessia Cimadamore and Antonio Lopez-Beltran",
year = "2019",
month = "11",
doi = "10.1016/j.humpath.2019.08.012",
language = "English (US)",
volume = "93",
pages = "6--15",
journal = "Human Pathology",
issn = "0046-8177",
publisher = "W.B. Saunders Ltd",

}

TY - JOUR

T1 - Predicting biochemical recurrence after radical prostatectomy

T2 - the role of prognostic grade group and index tumor nodule

AU - Vau, Nuno

AU - Henriques, Vanessa

AU - Cheng, Liang

AU - Blanca, Ana

AU - Fonseca, Jorge

AU - Montironi, Rodolfo

AU - Cimadamore, Alessia

AU - Lopez-Beltran, Antonio

PY - 2019/11

Y1 - 2019/11

N2 - The aim of the current study was to test whether the grade group assessed in the index tumor nodule predicts biochemical recurrence after surgery. The study cohort series included 144 consecutive patients treated by laparoscopic radical prostatectomy. The following parameters were evaluated in each case: type of radical prostatectomy (with/without lymphadenectomy), pT and pN status, histologic type of prostate carcinoma (acinar versus mixed histology), surgical margin resection status, perineural invasion, lymphovascular invasion, biochemical recurrence status, presence of tertiary Gleason 5 pattern, and grade group that was assessed both in overall prostate cancer and in index (dominant) tumor nodule. Twenty patients (13.9%) experienced postoperative biochemical recurrence at a mean follow-up time of 12.2 months. The univariate survival analysis selected type of radical prostatectomy, histological subtype, lymphovascular invasion, American Joint Committee on Cancer pT and pN classification, tertiary Gleason 5 pattern, preoperative serum prostate specific antigen level, and the grade group assessed in both the overall prostate and index tumor nodule as significant for biochemical recurrence-free survival. Type of radical prostatectomy (P = .020), histological subtype (P = .002), lymphovascular invasion (P = .023), tertiary Gleason pattern 5 (P = .016), and grade group classification in index tumor nodule (P ≤ .0001) were selected as independent predictors of biochemical recurrence-free survival. In conclusion, our results validate grade group in the index tumor nodule as an independent predictor of biochemical recurrence-free survival, thus emphasizing the value of reporting grade group in index tumor nodule. The main limitation of our study is the relatively low number of cases in the current series, suggesting the need of large confirmatory studies.

AB - The aim of the current study was to test whether the grade group assessed in the index tumor nodule predicts biochemical recurrence after surgery. The study cohort series included 144 consecutive patients treated by laparoscopic radical prostatectomy. The following parameters were evaluated in each case: type of radical prostatectomy (with/without lymphadenectomy), pT and pN status, histologic type of prostate carcinoma (acinar versus mixed histology), surgical margin resection status, perineural invasion, lymphovascular invasion, biochemical recurrence status, presence of tertiary Gleason 5 pattern, and grade group that was assessed both in overall prostate cancer and in index (dominant) tumor nodule. Twenty patients (13.9%) experienced postoperative biochemical recurrence at a mean follow-up time of 12.2 months. The univariate survival analysis selected type of radical prostatectomy, histological subtype, lymphovascular invasion, American Joint Committee on Cancer pT and pN classification, tertiary Gleason 5 pattern, preoperative serum prostate specific antigen level, and the grade group assessed in both the overall prostate and index tumor nodule as significant for biochemical recurrence-free survival. Type of radical prostatectomy (P = .020), histological subtype (P = .002), lymphovascular invasion (P = .023), tertiary Gleason pattern 5 (P = .016), and grade group classification in index tumor nodule (P ≤ .0001) were selected as independent predictors of biochemical recurrence-free survival. In conclusion, our results validate grade group in the index tumor nodule as an independent predictor of biochemical recurrence-free survival, thus emphasizing the value of reporting grade group in index tumor nodule. The main limitation of our study is the relatively low number of cases in the current series, suggesting the need of large confirmatory studies.

KW - Biochemical recurrence

KW - Grade groups

KW - Index nodule

KW - Index tumor

KW - Prostate cancer

KW - Radical prostatectomy

UR - http://www.scopus.com/inward/record.url?scp=85073687419&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85073687419&partnerID=8YFLogxK

U2 - 10.1016/j.humpath.2019.08.012

DO - 10.1016/j.humpath.2019.08.012

M3 - Article

C2 - 31442520

AN - SCOPUS:85073687419

VL - 93

SP - 6

EP - 15

JO - Human Pathology

JF - Human Pathology

SN - 0046-8177

ER -